COVID Risk Evaluation Now Up to Individuals
By Fumio Ohtake / Special to The Yomiuri Shimbun
10:30 JST, September 8, 2023
About four months have passed since COVID-19 was downgraded from the equivalentof a Category II disease to Category V on May 8, under Japan’s Infectious Diseases
Law.
Category V is part of this law, originally enacted in 1998 to “provide for necessary
measures concerning the prevention of infectious diseases and medical care for patientswith infectious diseases.” Defining such diseases, the law refers to a five-tierclassification from categories I to V, depending on contagion and aggravation risks, aswell as other groups including “infectious diseases such as new types of influenza.”
Category V infectious diseases include seasonal flu and measles. This category requires
no restriction on individuals’ activities. The government conducts surveys to keep thenation and medical institutions updated on the latest information on infection cases.
Category II’s infectious diseases include tuberculosis and avian influenza, with a related
article calling for the hospitalization of Category II patients and the disinfection of foodand drink as well as clothing, bedding and other physical items used by them. In thecase of categories I to III, not only hospitalization but also restrictions on personal
rights, including those on attendance at work, are permissible.
The reason COVID-19 was originally designated as “the equivalent of Category II”
instead of just Category II is because it was classified into the group covering“infectious diseases such as new types of influenza,” which is outside the five-categoryclassification framework.
This kind of designation permits the authorities to limit personal rights in a relatively
flexible manner in their efforts to prevent infections. Against such a backdrop, they took
measures in response to the equivalent of Category II. Consequently, not only COVID
patients but also asymptomatic carriers of the novel coronavirus were advised to behospitalized or to take other measures. This approach was in effect the equivalent totackling a Category I case, which covers infectious diseases with more perilous
symptoms.
The costs of such hospitalizations under the Infectious Diseases Law are fully coveredby public funds, largely because of the imposition of rigid restrictions on patients’
freedom of movement, not simply because of the severity of the diseases.
With COVID-19 designated as “the equivalent of Category II” and covered by the 2012
law on special measures for new types of influenza and other novel infections, thegovernment became capable of requesting not only coronavirus patients but also thosehaving had close contact with them to refrain from going out, thus limiting personal
rights. Further, when state-of-emergency declarations were in place, the central andlocal governments asked even people who had no close contact with infected patients toavoid outings and requested shops and stores to close.
The reason the government also became capable of asking people to wear masks andbusinesses to require employees at their workplaces to do so was the existence of thespecial measures law of 2012 that empowers it to restrict personal rights. One of theterms of application of the law is that “the conditions of a disease are considerably
severe compared to a seasonal flu.”
The fact that COVID-19, which is no longer within the coverage of the special measureslaw, has been recategorized as a Category V disease means that it has been judged to
not be serious enough to permit the government to limit the fundamental human rightsthat are guaranteed by the Constitution. This judgment is akin to people’s use ofvehicles despite their awareness of such risks as traffic accidents and environmental
degradation and so on. As we are faced with many risks in society, deciding which one
we should deal most seriously with depends on an individual’s sense of values.

Post-event scrutiny necessary
When the government formulates a new policy, experts well-versed in the related fieldprovide it and the nation with relevant scientific information. It goes without saying thatno political decision should contradict scientific information. That said, however, eachpolicy has multiple purposes that require value judgments, namely, determining what
information should be given more weight.

In the medical universe, evidence-based medicine (EBM) constitutes the mainstream of
health care decision-making focused on the effectiveness of treatments and medication.
In the event that something is not rigorously endorsed by evidence, it must not beapplied in practice. This mindset has become considerably dominant in the medicalworld. Consequently, there have been many cases where changes have been made tolong-established treatments.
There are, however, two notions about EBM. One goes that treatment should be chosenfrom multiple options based on evidence, while the other takes it for granted that theavailable evidence will point to only one possibility. The two notions differ as to theirimplications. To give an easy-to-understand analogy, consider two treatments: one
results in short-term recovery with severe side effects and the other requires long-term
recovery but with mild side effects. Which treatment is desirable? The answer should beleft to what each patient and/or the family members value. There can be no way for any
medical professional to automatically pick a treatment based on evidence.
The same is true of the government’s responses to the COVID pandemic.
Throughout the pandemic, experts kept policy decision-makers informed about how
effective state-of-emergency declarations and other measures to restrict people’s
activities would be in containing the spread of the novel coronavirus and how theywould affect society and the economy. The government-appointed advisorysubcommittees on responses to coronavirus infections and on the COVID basic action
policy — I have been on both — should have played a more proactive role in providing
information about the socioeconomic impact. In my opinion, as medical professionals
have had the largest share of both panels’ membership, expertise on socioeconomic
impact has not been sufficiently utilized.
The other issue has been that despite certain experts obtaining new information about
the state of novel coronavirus infections, there have even been delays in information
updates, resulting in information not being reflected in the latest government responses
to the pandemic.
When the government declared a coronavirus state of emergency for the first time, it
aimed to keep person-to-person contact 80% below what is usual. The goal was basedon a simulation that indicated that unless an 80% cut in person-to-person contact wasrealized, in just four weeks it would become impossible for Japan to keep the numbers

of infected patients below a certain threshold for its mainstay COVID containment
strategy, known as a cluster-based approach, to remain viable.
But a recent study that replicated the mathematical model used in connection with thefirst state-of-emergency declaration found that if person-to-person contact was lowered
to 80%, the number of newly infected patients would plummet to the government’s
target in just one day. What the study found has called into question the real necessity ofthe monthlong 80% reduction in person-to-person contact.
Of course, the original simulation — which was carried out so expeditiously when thecountry was in an emergency situation amid rapid COVID contagion — greatly
benefited society. Scientific evidence nevertheless has its limits, too. Therefore, given
insufficient data, we need to make judgments on the premise that highly accurate
simulations will not necessarily be available immediately.
Similar developments have been seen in global measures for preventing novel
coronavirus infections.
The World Health Organization initially stated the coronavirus was “transmitted
between people through respiratory droplets and contact routes.” Japan worked out aseries of measures based on this WHO scientific brief. As a result, shops and stores in
the country installed transparent acrylic panels and plastic sheets to prevent droplet
infection, while customers were asked to wear masks. Japanese researchers used theFugaku supercomputer to produce convincing simulation footage showing how
effective acrylic panels and plastic sheets were in preventing the flow of droplets.
However, on April 30, 2021, the WHO added aerosols to its list of ways the novel
coronavirus is transmitted. Aerosols are much smaller than droplets and can remain
airborne for longer. Then, the importance of ventilation to let fresh air into indoor
spaces increased as a measure to prevent the spread of the novel coronavirus. It also
became known that acrylic panels could have the opposite effect in terms of achieving
better ventilation because they obstruct the flow of air.
We learned that once an infection countermeasure takes root in society, people tend toremain entrenched in it for a long period of time even when the discovery of new
evidence casts doubt on the effectiveness of the original measure.

Any delay in evidence updates adversely affects both infection measures and socialactivities. Whenever evidence is updated, related measures must be brought up to date.
All COVID measures introduced thus far should be examined with a view to realigning
the policy-science relationship.

Fumio Ohtake
Ohtake is a specially appointed professor at the Center for Infectious Disease Educationand Research (CiDER) at Osaka University, where he served as an executive vicepresident in 2013-15. He was president of the Japanese Economic Association in 202021.

The original Japanese article appeared in the Sept. 3 issue of The Yomiuri Shimbun.